نتایج جستجو برای: ژن pah

تعداد نتایج: 23292  

2013
Alexander von Gise Stephen L. Archer Margaret R. MacLean Georg Hansmann

Pulmonary arterial hypertension (PAH) is characterized by progressive obliteration of pulmonary arterioles leading to increased pulmonary vascular resistance, right heart failure, and death in 30-60% of PAH patients five years after diagnosis. Although PAH is primarily a vascular disease, patients die from right ventricular failure. PAH is a panvasculopathy with key abnormalities evident in the...

2014
Yidan Zhao Jenny Peng Catherine Lu Michael Hsin Marco Mura Licun Wu Lei Chu Ricardo Zamel Tiago Machuca Thomas Waddell Mingyao Liu Shaf Keshavjee John Granton Marc de Perrot

Although multiple gene and protein expression have been extensively profiled in human pulmonary arterial hypertension (PAH), the mechanism for the development and progression of pulmonary hypertension remains elusive. Analysis of the global metabolomic heterogeneity within the pulmonary vascular system leads to a better understanding of disease progression. Using a combination of high-throughpu...

محمدی, حمید, کدیور, الهام, کفیل زاده, فرشید,

Background and Aim: In this research we isolated the bacterial species degrading polycyclic aromatic hydrocarbons (PAHs) and determined optimal salt concentration for PAH degradation.Materials and Methods: We used naphthalene and anthracene as the only sources of carbon for isolating PAH-degrading bacteria the main culture medium was ONR7a. The bacteria isolated by this method were used for the...

Journal: :Cardiovascular research 2011
Kevin White Yvonne Dempsie Margaret Nilsen Audrey F Wright Lynn Loughlin Margaret R MacLean

AIMS Idiopathic and familial forms of pulmonary arterial hypertension (PAH) predominantly affect females through an unknown mechanism. Activity of the serotonin transporter (SERT) may modulate the development of PAH, and mice overexpressing SERT (SERT+ mice) develop PAH and severe hypoxia-induced PAH. In the central nervous system, oestrogens influence activity of the serotonin system. Therefor...

2013
Jolyane Meloche Antony Courchesne Marjorie Barrier Sophie Carter Malik Bisserier Roxane Paulin Jean‐François Lauzon‐Joset Sandra Breuils‐Bonnet Ève Tremblay Sabrina Biardel Christine Racine Christian Courture Pierre Bonnet Susan M. Majka Yves Deshaies Frédéric Picard Steeve Provencher Sébastien Bonnet

BACKGROUND Pulmonary arterial hypertension (PAH) is a vasculopathy characterized by enhanced pulmonary artery smooth muscle cell (PASMC) proliferation and suppressed apoptosis. This results in both increase in pulmonary arterial pressure and pulmonary vascular resistance. Recent studies have shown the implication of the signal transducer and activator of transcription 3 (STAT3)/bone morphogenet...

2017
Yun-yun Zhang Fan Xu Ming Chu Li-qing Bi

OBJECTIVE To assess the incidence, possible risk factors and prognosis of pulmonary arterial hypertension (PAH) in critically ill elderly patients. METHODS We selected 122 cases admitted to the ICU, ages 60-93 years old. An echocardiography examination was performed within four days after admission to the ICU. PAH is usually suspected if the patient's pulmonary artery systolic pressure ≥ 40 m...

2015
Jean Joel R. Bigna Paule Sandra D. Sime Sinata Koulla-Shiro

The development of HIV related pulmonary arterial hypertension (PAH) reduces the probability of survival by half as compared with HIV-infected individuals without HIV related PAH. HIV infected patients have a greater incidence of PAH compared to general population and have a 2500-fold increased risk of developing PAH. It is therefore important to have a recent overview of the problem in Africa,...

Journal: :Circulation 2012
Robyn J Barst Michael D McGoon C Gregory Elliott Aimee J Foreman Dave P Miller D Dunbar Ivy

BACKGROUND Pulmonary arterial hypertension (PAH) is a rare but important cause of morbidity and mortality in children. METHODS AND RESULTS We analyzed data from 216 patients ≤18 years of age at diagnosis who were enrolled in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Median age at diagnosis and enrollment was 7 and 15 years, respectively. The most frequent p...

2012
Paola Caruso Yvonne Dempsie Hannah C. Stevens Robert A. McDonald Lu Long Ruifang Lu Kevin White Kirsty M. Mair John D. McClure Mark Southwood Paul Upton Mei Xin Eva van Rooij Eric N. Olson Nicholas W. Morrell Margaret R. MacLean Andrew H. Baker

Rationale: Despite improved understanding of the underlying genetics, pulmonary arterial hypertension (PAH) remains a severe disease. Extensive remodeling of small pulmonary arteries, including proliferation of pulmonary artery smooth muscle cells (PASMCs), characterizes PAH. MicroRNAs (miRNAs) are noncoding RNAs that have been shown to play a role in vascular remodeling. Objective: We assessed...

Journal: :Circulation research 2012
Paola Caruso Yvonne Dempsie Hannah C Stevens Robert A McDonald Lu Long Ruifang Lu Kevin White Kirsty M Mair John D McClure Mark Southwood Paul Upton Mei Xin Eva van Rooij Eric N Olson Nicholas W Morrell Margaret R MacLean Andrew H Baker

RATIONALE Despite improved understanding of the underlying genetics, pulmonary arterial hypertension (PAH) remains a severe disease. Extensive remodeling of small pulmonary arteries, including proliferation of pulmonary artery smooth muscle cells (PASMCs), characterizes PAH. MicroRNAs (miRNAs) are noncoding RNAs that have been shown to play a role in vascular remodeling. OBJECTIVE We assessed...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید